Key result
NT-proBNP >115 pmol/l was a strong independent predictor of ventricular dysfunction in emergency patients presenting with acute dyspnoea (OR 45.4; 95% CI 4.5-452.3).
Why the study?
Does NT-proBNP measurement accurately detect ventricular dysfunction in patients presenting to the emergency department with acute dyspnoea?
Observational (n=100)
Does NT-proBNP measurement accurately detect ventricular dysfunction in patients presenting to the emergency department with acute dyspnoea?
Effect estimate: AUC 0.957 (95% CI 0.918-0.996)
p-value: p=<0.001
NT-proBNP is a strong independent predictor for detecting ventricular dysfunction in patients presenting to the ED with acute dyspnea and can be used to monitor in-hospital outcomes.
No takes yet. Share an insight, caveat, or question.
May support ED risk stratification in acute dyspnea; extends BNP data but remains hypothesis-generating pending validation.
Bayés‐Genís et al. (2004) conducted an observational in Acute dyspnoea (n=100). NT-proBNP measurement vs. Non-cardiac dyspnoea (normal ventricular function) was evaluated on Detection of ventricular dysfunction (AUC 0.957, 95% CI 0.918-0.996, p=<0.001). NT-proBNP >115 pmol/l was a strong independent predictor of ventricular dysfunction in emergency patients presenting with acute dyspnoea (OR 45.4; 95% CI 4.5-452.3).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: